Core Scientific's Top Investor to Vote Against CoreWeave's 'Inadequate' $9B Takeover
Two Seas Capital is challenging Core Scientific’s $9 billion sale to CoreWeave, arguing the terms significantly undervalue the miner.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Strategy tells MSCI ‘Bitcoin doesn’t need you’ as $2.8 billion index risk hangs over MSTR
Strategy faces a renewed threat of removal from major MSCI equity indexes under a broader screening proposal that could trigger an...
Bitcoin’s $16.3 billion Wall Street stress test splits into four positional patterns
The $16.3 billion in Bitcoin ETF positions that CryptoSlate recently tracked ahead of the Q2 filing deadline resolved into four di...
SEC Charges Goliath Ventures in Alleged $425M Crypto Ponzi Scheme Targeting 1,300 Investors
Key Takeaways: SEC claims that Goliath is responsible for the raising of at least $425M from 1,300+ investors. Investors were prom...
SEC Delays Vote on Exemptions for Crypto Fundraising
In SEC crypto news today, the Securities and Exchange Commission canceled its August 14 open meeting, which had been scheduled to...
Russia Caps Crypto Buying at 300,000 Rubles for Retail Investors Under New Rules
Key Takeaways: Russia offers non-qualified investors a limit of purchasing up to 300,000 rubles worth of crypto per year via inter...
Institutional investor Paul Tudor Jones adds 109,446 BlackRock Bitcoin ETF shares while cutting calls by 85%
Tudor Investment reported 18.9% more direct shares in BlackRock's iShares Bitcoin Trust ETF at June 30 than it held three months e...